Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 65 entries
Sorted by: Best Match Show Resources per page
An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?.

Expert review of respiratory medicine

Cazzola M, Rogliani P, Puxeddu E, Ora J, Matera MG.
PMID: 29082808
Expert Rev Respir Med. 2018 Jan;12(1):43-54. doi: 10.1080/17476348.2018.1398086. Epub 2017 Nov 03.

INTRODUCTION: Treatment recommendations are based on randomized controlled trials (RCTs). However, only about 1 in 20 people meet the inclusion criteria for RCTs forming consensus guidelines in chronic obstructive pulmonary disease (COPD). Consequently, the one-size-fits-all approach focused merely on...

Cite
Cazzola M, Rogliani P, Puxeddu E, et al. An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?. Expert Rev Respir Med. 2017;12(1):43-54doi: 10.1080/17476348.2018.1398086.
Cazzola, M., Rogliani, P., Puxeddu, E., Ora, J., & Matera, M. G. (2018). An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?. Expert review of respiratory medicine, 12(1), 43-54. https://doi.org/10.1080/17476348.2018.1398086
Cazzola, Mario, et al. "An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?." Expert review of respiratory medicine vol. 12,1 (2018): 43-54. doi: https://doi.org/10.1080/17476348.2018.1398086
Cazzola M, Rogliani P, Puxeddu E, Ora J, Matera MG. An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?. Expert Rev Respir Med. 2018 Jan;12(1):43-54. doi: 10.1080/17476348.2018.1398086. Epub 2017 Nov 03. PMID: 29082808.
Copy Download .nbib Format: NLM
Bi-allelic Mutations in KLHL7 Cause a Crisponi/CISS1-like Phenotype Associated with Early-Onset Retinitis Pigmentosa.

American journal of human genetics

Angius A, Uva P, Buers I, Oppo M, Puddu A, Onano S, Persico I, Loi A, Marcia L, Höhne W, Cuccuru G, Fotia G, Deiana M, Marongiu M, Atalay HT, Inan S, El Assy O, Smit LME, Okur I, Boduroglu K, Utine GE, Kılıç E, Zampino G, Crisponi G, Crisponi L, Rutsch F.
PMID: 29625027
Am J Hum Genet. 2018 Apr 05;102(4):713. doi: 10.1016/j.ajhg.2018.03.020.

No abstract available.

Cite
Angius A, Uva P, Buers I, et al. Bi-allelic Mutations in KLHL7 Cause a Crisponi/CISS1-like Phenotype Associated with Early-Onset Retinitis Pigmentosa. Am J Hum Genet. 2018;102(4):713doi: 10.1016/j.ajhg.2018.03.020.
Angius, A., Uva, P., Buers, I., Oppo, M., Puddu, A., Onano, S., Persico, I., Loi, A., Marcia, L., Höhne, W., Cuccuru, G., Fotia, G., Deiana, M., Marongiu, M., Atalay, H. T., Inan, S., El Assy, O., Smit, L. M. E., Okur, I., Boduroglu, K., Utine, G. E., Kılıç, E., Zampino, G., Crisponi, G., Crisponi, L., & Rutsch, F. (2018). Bi-allelic Mutations in KLHL7 Cause a Crisponi/CISS1-like Phenotype Associated with Early-Onset Retinitis Pigmentosa. American journal of human genetics, 102(4), 713. https://doi.org/10.1016/j.ajhg.2018.03.020
Angius, Andrea, et al. "Bi-allelic Mutations in KLHL7 Cause a Crisponi/CISS1-like Phenotype Associated with Early-Onset Retinitis Pigmentosa." American journal of human genetics vol. 102,4 (2018): 713. doi: https://doi.org/10.1016/j.ajhg.2018.03.020
Angius A, Uva P, Buers I, Oppo M, Puddu A, Onano S, Persico I, Loi A, Marcia L, Höhne W, Cuccuru G, Fotia G, Deiana M, Marongiu M, Atalay HT, Inan S, El Assy O, Smit LME, Okur I, Boduroglu K, Utine GE, Kılıç E, Zampino G, Crisponi G, Crisponi L, Rutsch F. Bi-allelic Mutations in KLHL7 Cause a Crisponi/CISS1-like Phenotype Associated with Early-Onset Retinitis Pigmentosa. Am J Hum Genet. 2018 Apr 05;102(4):713. doi: 10.1016/j.ajhg.2018.03.020. PMID: 29625027; PMCID: PMC5985354.
Copy Download .nbib Format: NLM
Diagnostic Performance and Safety of Bronchoalveolar Lavage in Thrombocytopenic Haematological Patients for Invasive Fungal Infections Diagnosis: A Monocentric, Retrospective Experience.

Mediterranean journal of hematology and infectious diseases

Cefalo M, Puxeddu E, Sarmati L, Paterno G, Fontana C, Nasso D, Pane G, De Bellis E, Palmieri R, Buzzati E, Meconi F, Laureana R, Casciani P, Zizzari AG, Rogliani P, de Fabritiis P, Maurillo L, Buccisano F, Cantonetti M, Arcese W, Venditti A, Del Principe MI.
PMID: 31700590
Mediterr J Hematol Infect Dis. 2019 Nov 01;11(1):e2019065. doi: 10.4084/MJHID.2019.065. eCollection 2019.

BACKGROUND: Although bronchoalveolar lavage (BAL) measurements of galactomannan antigen (GM) seems to be more sensitive than serum testing to detect invasive fungal infection (IFI), a consensus on the most appropriate diagnostic threshold of the BAL GM test is still...

Cite
Cefalo M, Puxeddu E, Sarmati L, et al. Diagnostic Performance and Safety of Bronchoalveolar Lavage in Thrombocytopenic Haematological Patients for Invasive Fungal Infections Diagnosis: A Monocentric, Retrospective Experience. Mediterr J Hematol Infect Dis. 2019;11(1):e2019065doi: 10.4084/MJHID.2019.065.
Cefalo, M., Puxeddu, E., Sarmati, L., Paterno, G., Fontana, C., Nasso, D., Pane, G., De Bellis, E., Palmieri, R., Buzzati, E., Meconi, F., Laureana, R., Casciani, P., Zizzari, A. G., Rogliani, P., de Fabritiis, P., Maurillo, L., Buccisano, F., Cantonetti, M., Arcese, W., Venditti, A., & Del Principe, M. I. (2019). Diagnostic Performance and Safety of Bronchoalveolar Lavage in Thrombocytopenic Haematological Patients for Invasive Fungal Infections Diagnosis: A Monocentric, Retrospective Experience. Mediterranean journal of hematology and infectious diseases, 11(1), e2019065. https://doi.org/10.4084/MJHID.2019.065
Cefalo, Mariagiovanna, et al. "Diagnostic Performance and Safety of Bronchoalveolar Lavage in Thrombocytopenic Haematological Patients for Invasive Fungal Infections Diagnosis: A Monocentric, Retrospective Experience." Mediterranean journal of hematology and infectious diseases vol. 11,1 (2019): e2019065. doi: https://doi.org/10.4084/MJHID.2019.065
Cefalo M, Puxeddu E, Sarmati L, Paterno G, Fontana C, Nasso D, Pane G, De Bellis E, Palmieri R, Buzzati E, Meconi F, Laureana R, Casciani P, Zizzari AG, Rogliani P, de Fabritiis P, Maurillo L, Buccisano F, Cantonetti M, Arcese W, Venditti A, Del Principe MI. Diagnostic Performance and Safety of Bronchoalveolar Lavage in Thrombocytopenic Haematological Patients for Invasive Fungal Infections Diagnosis: A Monocentric, Retrospective Experience. Mediterr J Hematol Infect Dis. 2019 Nov 01;11(1):e2019065. doi: 10.4084/MJHID.2019.065. eCollection 2019. PMID: 31700590; PMCID: PMC6827601.
Copy Download .nbib Format: NLM
Evaluation of Audiological Results and Cochleo-Vestibular Subclinical Injury After CO.

Lasers in surgery and medicine

Mariani C, Carta F, Piras N, Marrosu V, Serra F, De Seta D, Puxeddu R.
PMID: 34004037
Lasers Surg Med. 2021 Nov;53(9):1186-1191. doi: 10.1002/lsm.23416. Epub 2021 May 18.

BACKGROUND AND OBJECTIVES: Evaluation of the effectiveness and safety of COSTUDY DESIGN/MATERIALS AND METHODS: Retrospective clinical trial on 38 patients with the diagnosis of otosclerosis, who underwent CORESULTS: Postoperative ABG closure within 10 dB was obtained in 35 cases...

Cite
Mariani C, Carta F, Piras N, et al. Evaluation of Audiological Results and Cochleo-Vestibular Subclinical Injury After CO. Lasers Surg Med. 2021;53(9):1186-1191doi: 10.1002/lsm.23416.
Mariani, C., Carta, F., Piras, N., Marrosu, V., Serra, F., De Seta, D., & Puxeddu, R. (2021). Evaluation of Audiological Results and Cochleo-Vestibular Subclinical Injury After CO. Lasers in surgery and medicine, 53(9), 1186-1191. https://doi.org/10.1002/lsm.23416
Mariani, Cinzia, et al. "Evaluation of Audiological Results and Cochleo-Vestibular Subclinical Injury After CO." Lasers in surgery and medicine vol. 53,9 (2021): 1186-1191. doi: https://doi.org/10.1002/lsm.23416
Mariani C, Carta F, Piras N, Marrosu V, Serra F, De Seta D, Puxeddu R. Evaluation of Audiological Results and Cochleo-Vestibular Subclinical Injury After CO. Lasers Surg Med. 2021 Nov;53(9):1186-1191. doi: 10.1002/lsm.23416. Epub 2021 May 18. PMID: 34004037.
Copy Download .nbib Format: NLM
Transoral-transpharyngeal CO.

Clinical case reports

Mariani C, Carta F, De Seta D, Nazhmudinov II, Guseinov IG, Magomedova KM, Chuchueva N, Marrosu V, Puxeddu R.
PMID: 33363906
Clin Case Rep. 2020 Sep 30;8(12):3198-3203. doi: 10.1002/ccr3.3372. eCollection 2020 Dec.

Recurrent nerve laryngeal schwannoma is a rare benign tumor that, in expert hands, can be treated by transoral CO

Cite
Mariani C, Carta F, De Seta D, et al. Transoral-transpharyngeal CO. Clin Case Rep. 2020;8(12):3198-3203doi: 10.1002/ccr3.3372.
Mariani, C., Carta, F., De Seta, D., Nazhmudinov, I. I., Guseinov, I. G., Magomedova, K. M., Chuchueva, N., Marrosu, V., & Puxeddu, R. (2020). Transoral-transpharyngeal CO. Clinical case reports, 8(12), 3198-3203. https://doi.org/10.1002/ccr3.3372
Mariani, Cinzia, et al. "Transoral-transpharyngeal CO." Clinical case reports vol. 8,12 (2020): 3198-3203. doi: https://doi.org/10.1002/ccr3.3372
Mariani C, Carta F, De Seta D, Nazhmudinov II, Guseinov IG, Magomedova KM, Chuchueva N, Marrosu V, Puxeddu R. Transoral-transpharyngeal CO. Clin Case Rep. 2020 Sep 30;8(12):3198-3203. doi: 10.1002/ccr3.3372. eCollection 2020 Dec. PMID: 33363906; PMCID: PMC7752612.
Copy Download .nbib Format: NLM
Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

Ora J, Coppola A, Perduno A, Manzetti GM, Puxeddu E, Rogliani P.
PMID: 34634897
Monaldi Arch Chest Dis. 2021 Oct 11; doi: 10.4081/monaldi.2021.1925. Epub 2021 Oct 11.

Ambulatory oxygen therapy (AOT) is commonly prescribed in Interstitial Lung Disease (ILD) patients, with the aim of reducing dyspnea and increasing exercise tolerance. Despite its frequent use and a reasonable physiological rationale, there is a lack of evidence supporting...

Cite
Ora J, Coppola A, Perduno A, et al. Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients. Monaldi Arch Chest Dis. 2021;doi: 10.4081/monaldi.2021.1925.
Ora, J., Coppola, A., Perduno, A., Manzetti, G. M., Puxeddu, E., & Rogliani, P. (2021). Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, . https://doi.org/10.4081/monaldi.2021.1925
Ora, Josuel, et al. "Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients." Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace vol. (2021). doi: https://doi.org/10.4081/monaldi.2021.1925
Ora J, Coppola A, Perduno A, Manzetti GM, Puxeddu E, Rogliani P. Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients. Monaldi Arch Chest Dis. 2021 Oct 11; doi: 10.4081/monaldi.2021.1925. Epub 2021 Oct 11. PMID: 34634897.
Copy Download .nbib Format: NLM
Modularity maximization as a flexible and generic framework for brain network exploratory analysis.

NeuroImage

Zamani Esfahlani F, Jo Y, Puxeddu MG, Merritt H, Tanner JC, Greenwell S, Patel R, Faskowitz J, Betzel RF.
PMID: 34607022
Neuroimage. 2021 Dec 01;244:118607. doi: 10.1016/j.neuroimage.2021.118607. Epub 2021 Oct 02.

The modular structure of brain networks supports specialized information processing, complex dynamics, and cost-efficient spatial embedding. Inter-individual variation in modular structure has been linked to differences in performance, disease, and development. There exist many data-driven methods for detecting and...

Cite
Zamani Esfahlani F, Jo Y, Puxeddu MG, et al. Modularity maximization as a flexible and generic framework for brain network exploratory analysis. Neuroimage. 2021;244:118607doi: 10.1016/j.neuroimage.2021.118607.
Zamani Esfahlani, F., Jo, Y., Puxeddu, M. G., Merritt, H., Tanner, J. C., Greenwell, S., Patel, R., Faskowitz, J., & Betzel, R. F. (2021). Modularity maximization as a flexible and generic framework for brain network exploratory analysis. NeuroImage, 244118607. https://doi.org/10.1016/j.neuroimage.2021.118607
Zamani Esfahlani, Farnaz, et al. "Modularity maximization as a flexible and generic framework for brain network exploratory analysis." NeuroImage vol. 244 (2021): 118607. doi: https://doi.org/10.1016/j.neuroimage.2021.118607
Zamani Esfahlani F, Jo Y, Puxeddu MG, Merritt H, Tanner JC, Greenwell S, Patel R, Faskowitz J, Betzel RF. Modularity maximization as a flexible and generic framework for brain network exploratory analysis. Neuroimage. 2021 Dec 01;244:118607. doi: 10.1016/j.neuroimage.2021.118607. Epub 2021 Oct 02. PMID: 34607022.
Copy Download .nbib Format: NLM
Repeatability and reproducibility of deep-learning-based liver volume and Couinaud segment volume measurement tool.

Abdominal radiology (New York)

Mojtahed A, Núñez L, Connell J, Fichera A, Nicholls R, Barone A, Marieiro M, Puddu A, Arya Z, Ferreira C, Ridgway G, Kelly M, Lamb HJ, Caseiro-Alves F, Brady JM, Banerjee R.
PMID: 34605963
Abdom Radiol (NY). 2021 Oct 04; doi: 10.1007/s00261-021-03262-x. Epub 2021 Oct 04.

PURPOSE: Volumetric and health assessment of the liver is crucial to avoid poor post-operative outcomes following liver resection surgery. No current methods allow for concurrent and accurate measurement of both Couinaud segmental volumes for future liver remnant estimation and...

Cite
Mojtahed A, Núñez L, Connell J, et al. Repeatability and reproducibility of deep-learning-based liver volume and Couinaud segment volume measurement tool. Abdom Radiol (NY). 2021;doi: 10.1007/s00261-021-03262-x.
Mojtahed, A., Núñez, L., Connell, J., Fichera, A., Nicholls, R., Barone, A., Marieiro, M., Puddu, A., Arya, Z., Ferreira, C., Ridgway, G., Kelly, M., Lamb, H. J., Caseiro-Alves, F., Brady, J. M., & Banerjee, R. (2021). Repeatability and reproducibility of deep-learning-based liver volume and Couinaud segment volume measurement tool. Abdominal radiology (New York), . https://doi.org/10.1007/s00261-021-03262-x
Mojtahed, Amirkasra, et al. "Repeatability and reproducibility of deep-learning-based liver volume and Couinaud segment volume measurement tool." Abdominal radiology (New York) vol. (2021). doi: https://doi.org/10.1007/s00261-021-03262-x
Mojtahed A, Núñez L, Connell J, Fichera A, Nicholls R, Barone A, Marieiro M, Puddu A, Arya Z, Ferreira C, Ridgway G, Kelly M, Lamb HJ, Caseiro-Alves F, Brady JM, Banerjee R. Repeatability and reproducibility of deep-learning-based liver volume and Couinaud segment volume measurement tool. Abdom Radiol (NY). 2021 Oct 04; doi: 10.1007/s00261-021-03262-x. Epub 2021 Oct 04. PMID: 34605963.
Copy Download .nbib Format: NLM
Emerging Role of Caveolin-1 in GLP-1 Action.

Frontiers in endocrinology

Puddu A, Maggi D.
PMID: 33935978
Front Endocrinol (Lausanne). 2021 Apr 14;12:668012. doi: 10.3389/fendo.2021.668012. eCollection 2021.

Glucagon-like peptide-1 (GLP-1) is a gut hormone mainly produced in the intestinal epithelial endocrine L cells, involved in maintaining glucose homeostasis. The use of GLP-1 analogous and dipeptidyl peptidase-IV (DPP-IV) inhibitors is well-established in Type 2 Diabetes. The efficacy...

Cite
Puddu A, Maggi D. Emerging Role of Caveolin-1 in GLP-1 Action. Front Endocrinol (Lausanne). 2021;12:668012doi: 10.3389/fendo.2021.668012.
Puddu, A., & Maggi, D. (2021). Emerging Role of Caveolin-1 in GLP-1 Action. Frontiers in endocrinology, 12668012. https://doi.org/10.3389/fendo.2021.668012
Puddu, Alessandra, and Maggi, Davide. "Emerging Role of Caveolin-1 in GLP-1 Action." Frontiers in endocrinology vol. 12 (2021): 668012. doi: https://doi.org/10.3389/fendo.2021.668012
Puddu A, Maggi D. Emerging Role of Caveolin-1 in GLP-1 Action. Front Endocrinol (Lausanne). 2021 Apr 14;12:668012. doi: 10.3389/fendo.2021.668012. eCollection 2021. PMID: 33935978; PMCID: PMC8079975.
Copy Download .nbib Format: NLM
What Is New in Thyroid Cancer: The Special Issue of the Journal Cancers.

Cancers

Puxeddu E, Tallini G, Vanni R.
PMID: 33086491
Cancers (Basel). 2020 Oct 19;12(10). doi: 10.3390/cancers12103036.

The incidence of thyroid cancer has increased over the past 3 to 4 decades. Nonetheless, the mortality from thyroid cancer has remained stable. The thyroid gland may develop nodules encompassing several types of cell proliferation, from frankly benign to...

Cite
Puxeddu E, Tallini G, Vanni R. What Is New in Thyroid Cancer: The Special Issue of the Journal Cancers. Cancers (Basel). 2020;12(10)doi: 10.3390/cancers12103036.
Puxeddu, E., Tallini, G., & Vanni, R. (2020). What Is New in Thyroid Cancer: The Special Issue of the Journal Cancers. Cancers, 12(10), . https://doi.org/10.3390/cancers12103036
Puxeddu, Efisio, et al. "What Is New in Thyroid Cancer: The Special Issue of the Journal Cancers." Cancers vol. 12,10 (2020). doi: https://doi.org/10.3390/cancers12103036
Puxeddu E, Tallini G, Vanni R. What Is New in Thyroid Cancer: The Special Issue of the Journal Cancers. Cancers (Basel). 2020 Oct 19;12(10). doi: 10.3390/cancers12103036. PMID: 33086491; PMCID: PMC7603182.
Copy Download .nbib Format: NLM
Immune Landscape of Thyroid Cancers: New Insights.

Frontiers in endocrinology

Menicali E, Guzzetti M, Morelli S, Moretti S, Puxeddu E.
PMID: 33986723
Front Endocrinol (Lausanne). 2021 Apr 27;11:637826. doi: 10.3389/fendo.2020.637826. eCollection 2020.

Immune system plays a key role in cancer prevention as well as in its initiation and progression. During multistep development of tumors, cells must acquire the capability to evade immune destruction. Both

Cite
Menicali E, Guzzetti M, Morelli S, et al. Immune Landscape of Thyroid Cancers: New Insights. Front Endocrinol (Lausanne). 2021;11:637826doi: 10.3389/fendo.2020.637826.
Menicali, E., Guzzetti, M., Morelli, S., Moretti, S., & Puxeddu, E. (2020). Immune Landscape of Thyroid Cancers: New Insights. Frontiers in endocrinology, 11637826. https://doi.org/10.3389/fendo.2020.637826
Menicali, Elisa, et al. "Immune Landscape of Thyroid Cancers: New Insights." Frontiers in endocrinology vol. 11 (2020): 637826. doi: https://doi.org/10.3389/fendo.2020.637826
Menicali E, Guzzetti M, Morelli S, Moretti S, Puxeddu E. Immune Landscape of Thyroid Cancers: New Insights. Front Endocrinol (Lausanne). 2021 Apr 27;11:637826. doi: 10.3389/fendo.2020.637826. eCollection 2020. PMID: 33986723; PMCID: PMC8112200.
Copy Download .nbib Format: NLM
Synergy across the drugs approved for the treatment of asthma.

Minerva medica

Rogliani P, Ritondo BL, Cavalli F, Giorgino F, Girolami A, Pane G, Pezzuto G, Zerillo B, Puxeddu E, Ora J.
PMID: 33496162
Minerva Med. 2021 Jan 26; doi: 10.23736/S0026-4806.21.07266-9. Epub 2021 Jan 26.

INTRODUCTION: Inhaled corticosteroids are the cornerstone for the treatment of stable asthma, however, when disease severity increases, escalating therapy to combinations of drugs acting on distinct signalling pathways is required. It is advantageous to providing evidence of a synergistic...

Cite
Rogliani P, Ritondo BL, Cavalli F, et al. Synergy across the drugs approved for the treatment of asthma. Minerva Med. 2021;doi: 10.23736/S0026-4806.21.07266-9.
Rogliani, P., Ritondo, B. L., Cavalli, F., Giorgino, F., Girolami, A., Pane, G., Pezzuto, G., Zerillo, B., Puxeddu, E., & Ora, J. (2021). Synergy across the drugs approved for the treatment of asthma. Minerva medica, . https://doi.org/10.23736/S0026-4806.21.07266-9
Rogliani, Paola, et al. "Synergy across the drugs approved for the treatment of asthma." Minerva medica vol. (2021). doi: https://doi.org/10.23736/S0026-4806.21.07266-9
Rogliani P, Ritondo BL, Cavalli F, Giorgino F, Girolami A, Pane G, Pezzuto G, Zerillo B, Puxeddu E, Ora J. Synergy across the drugs approved for the treatment of asthma. Minerva Med. 2021 Jan 26; doi: 10.23736/S0026-4806.21.07266-9. Epub 2021 Jan 26. PMID: 33496162.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 65 entries